Valeant Pharmaceuticals’ stock dive “is a gross overreaction in the market caused by charges thus far that are unsubstantiated and denied by Valeant," says Smith School finance professor David Kass, a long-time observer of Valeant stock and former health economist for the Federal Trade Commission. Read more...
In collaboration with University Archives, we present this spooky story on 14 allegedly haunted places at the University of Maryland. After reading through this creepy collection, we know you will want to find out more.
The fourth annual Smith School Business Summit will be Nov. 13, 2015, at the Baltimore Marriott Inner Harbor at Camden Yards.
Fall 2015 edition of Smith Business magazine.
When it comes to generating revenue, the U.S. health care system sometimes rewards quantity over quality. Fixing the flawed incentives will require greater transparency about the costs and values of services, experts said Oct. 9-10, 2015, at the sixth annual Workshop on Health IT and Economics, hosted by the Center for Health Information and Decision Systems (CHIDS) at the University of Maryland’s Robert H. Smith School of Business.